Incyte Corp. sell BMO Capital Markets
Start price
30.07.25
/
50%
€67.88
Target price
30.07.26
€51.87
Performance (%)
36.33%
Price
12:26
€92.54
Summary
This prediction is currently active. The SELL prediction by BMO_Capital_Markets for Incyte Corp. is trending in the completely wrong direction and now has a performance of 36.33%. This prediction currently runs until 30.07.26. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | 8.120% | 8.120% |
| iShares Core DAX® | -2,80 % | -1,40 % |
| iShares Nasdaq 100 | -6,35 % | -0,41 % |
| iShares Nikkei 225® | -6,94 % | -0,28 % |
| iShares S&P 500 | -3,41 % | 0,40 % |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Corporation (NASDAQ: INCY) had its price target raised by analysts at BMO Capital Markets from $52.00 to $60.00. They now have an "underperform" rating on the stock.
Ratings data for INCY provided by MarketBeat